Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

NCT00180921 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Head and Neck
Carcinoma, Adenoid Cystic

Interventions

DRUG: Imatinib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris